HDI Publications by date
Search will default to “all years” unless you filter by a specific year below.
Real-world evidence for patient outcomes and mutational burden in non-small cell lung (NSCLC) cancer patients in England using EGFR biomarker test data from routine clinical care
Hagenaars S, Ingleby FC, Lambova A, Gaultney J, Parimi M, Huynh J, Benson S, Muwaffak M, Jose S, Frayling L, ...
Real-world outcomes and biomarker testing in cancer patients: exploration of a novel genetic database from routine clinical practice in England
Real-world outcomes and biomarker testing in cancer patients: exploration of a novel genetic database from ...
First-line treatment patterns and overall survival of patients with advanced Merkel cell carcinoma in England from 2013-2022: Results of a nationwide observational cohort study
First-line treatment (tx) patterns and overall survival (OS) of patients (pts) with advanced Merkel cell carcinoma ...
First-line treatment patterns and overall survival of patients with advanced Merkel cell carcinoma in England from 2013-2022: results of a nationwide observational cohort study
Knott CS, Mahmoudpour SH, Kearney M, Boutmy E, Verpillat P. First-line treatment patterns and overall survival of ...
Evidence into practice: a national cohort study of NICE-recommended oncological drug therapy utilisation among women diagnosed with invasive breast cancer in England
Gannon MR, Dodwell D, Aggarwal A, Park MH, Miller K, Horgan K, et al. Br J Cancer 2023. ...
P47 Treatment pathways of patients diagnosed with hepatocellular carcinoma (HCC) after initial locoregional treatment in England
P47 Treatment pathways of patients diagnosed with hepatocellular carcinoma (HCC) after initial locoregional ...
Estimating surgery, radiotherapy and systemic anti-cancer therapy treatment costs for cancer patients by stage at diagnosis
Wills, L., Nagarwalla, D., Pearson, C. et al. Estimating surgery, radiotherapy and systemic anti-cancer therapy ...
Treatments into Routine Clinical Practice for the Treatment of Patients with Advanced or Metastatic Cancers
Mahmoudpour SH, Knott CS, Amin A, Boutmy E, Verpillat P. Integration of Immuno-oncology (IO) Treatments into ...
Outcomes of dostarlimab versus chemotherapy in post-platinum patients with recurrent/advanced endometrial cancer
Goulden S, Heffernan K, Sen Nikitas F, et al. Outcomes of dostarlimab versus chemotherapy in post-platinum ...
Completeness of endocrine therapy information in the Primary Care Prescription Database (PCPD) and secondary care treatment datasets: A national population-based cohort study using routine healthcare data
Gannon MR, Dodwell D, Miller K, Horgan K, Clements K, Medina J, et al.Cancer Epidemiology, Volume 86, ...
No results found.